Evidence map›Paper›PMID 36550132›Full record

ArticleNature communications2022

Exon junction complex shapes the m

Xin Yang, Robinson Triboulet, Qi Liu, Erdem Sendinc, Richard I Gregory

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 142 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. mNature reviews. Neuroscience · 2026
    Review
  8. Article
  9. Article
  10. Single-molecule mbioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Systematic identification of tissue-conserved mbioRxiv : the preprint server for biology · 2026
    Article
  18. High-stoichiometry mRNA (New York, N.Y.) · 2026
    Article
  19. Seven wonders of RNA modification biology.RNA (New York, N.Y.) · 2026
    Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Xin YangStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA.ORCID 0000-0001-6632-9608
Robinson TribouletStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA.
Qi LiuStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA.
Erdem SendincStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA.
Richard I GregoryStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA. rgregory@enders.tch.harvard.edu.ORCID 0000-0001-8090-8673
Boston Children's Hospital · US

Funding

Role of the Epitranscriptome in CancerR35CA232115 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREGORY, RICHARD I. · 2019 to 2025
$7.2M
Role of METTL3 and the m6A Epitranscriptome in cancerR01CA233671 · NCI · BOSTON CHILDREN'S HOSPITAL · PI GREGORY, RICHARD I., KIM, CARLA F. · 2020 to 2024
$3.2M
NCI NIH HHS R01 CA233671NCI NIH HHS R35 CA232115
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

Cell NucleusRNA SplicingExonsRNA, MessengerRNA StabilityRNA, Messenger

Identifiers

PMID36550132
PMCPMC9780246
OpenAlexW4312155712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.